Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease
- PMID: 7545530
- DOI: 10.1093/gerona/50a.5.b315
Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease
Abstract
The levels of specific neuropeptides and the activity of neuropeptidases known to degrade neuropeptides have been shown to be altered in senile dementia of the Alzheimer's type (SDAT) postmortem brain. We examined the metabolism of exogenous substance P, a neuropeptide with a putative role in SDAT pathology, in human postmortem temporal cortex, hippocampus, and caudate membrane homogenates from SDAT and sex- and age-matched control brain. The activity of two neuropeptidases known to metabolize substance P, neutral endopeptidase E.C.3.4.24.11 and metalloendopeptidase E.C.3.4.24.15, was also determined in the same postmortem, human tissue samples. The metabolic half-life of substance P was significantly increased in SDAT, postmortem, temporal cortex. The increased half-life of substance P was correlated with a decreased activity of the metabolic enzyme metalloendopeptidase 24.15 in temporal cortex. Substance P metabolism was not significantly altered in hippocampus or caudate tissues from SDAT brain compared to controls. The alteration of neuropeptidases demonstrated in this study and as shown by altered substance P metabolism may have a significant effect on the level of several biologically important neuropeptides in SDAT brain.
Similar articles
-
Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease.J Gerontol. 1992 Jan;47(1):B18-25. doi: 10.1093/geronj/47.1.b18. J Gerontol. 1992. PMID: 1346149
-
Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.Ann N Y Acad Sci. 1997 Apr 24;814:30-9. doi: 10.1111/j.1749-6632.1997.tb46142.x. Ann N Y Acad Sci. 1997. PMID: 9160957
-
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.J Neural Transm (Vienna). 1998;105(4-5):423-38. doi: 10.1007/s007020050068. J Neural Transm (Vienna). 1998. PMID: 9720972
-
[A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].Rinsho Byori. 1996 Mar;44(3):225-30. Rinsho Byori. 1996. PMID: 8857164 Review. Japanese.
-
[Degradation of substance P--biological activity of the products].Postepy Biochem. 1992;38(3):123-7. Postepy Biochem. 1992. PMID: 1281327 Review. Polish. No abstract available.
Cited by
-
Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease.Front Mol Neurosci. 2019 Jan 11;11:493. doi: 10.3389/fnmol.2018.00493. eCollection 2018. Front Mol Neurosci. 2019. PMID: 30687008 Free PMC article. Review.
-
Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17. J Cell Mol Med. 2024. PMID: 37847125 Free PMC article. Review.
-
Identification and characterization of Aβ peptide interactors in Alzheimer's disease by structural approaches.Front Aging Neurosci. 2014 Oct 9;6:265. doi: 10.3389/fnagi.2014.00265. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25346686 Free PMC article.
-
The Double-Edged Effects of Substance P in the Pathology of Alzheimer's Disease.Aging Dis. 2024 Oct 15;16(5):2870-2889. doi: 10.14336/AD.2024.0960. Aging Dis. 2024. PMID: 39500351 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical